The emerging approach of this peptide represents a major breakthrough in the care of the condition. Distinct from existing therapies, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide031617.blogofoto.com/73506286/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment